Linzhao Li
Overview
Explore the profile of Linzhao Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Li L, Yuan H, Gui H, Wan Q, Wang M, et al.
Clin Exp Immunol
. 2025 Mar;
PMID: 40079116
Introduction: Immunotherapy has rapidly become a primary treatment option for many lung cancer patients because of its success in treating this prevalent and deadly disease. However, the success of immunotherapy...
2.
Gui H, Nie Y, Yuan H, Wang M, Li L, Zhu L, et al.
Int Immunopharmacol
. 2024 Dec;
146():113918.
PMID: 39718058
Introduction: Depression negatively impacts the prognosis of various cancers, including lung cancer, by influencing antitumor immune responses and impairing immune cell function. Antidepressants may modulate the tumor immune microenvironment, enhancing...
3.
Gui H, Nie Y, Yuan H, Jing Q, Li L, Zhu L, et al.
Oncol Rep
. 2024 Sep;
52(5).
PMID: 39301655
Lung cancer is increasingly recognized as a leading cause of cancer‑related mortality. Immunotherapy has emerged as a promising therapeutic approach for lung cancer, particularly non‑small cell lung cancer (NSCLC). Nonetheless,...
4.
Zeng Y, Ren X, Jin P, Fan Z, Liu M, Zhang Y, et al.
Expert Opin Drug Discov
. 2024 Jul;
19(9):1125-1148.
PMID: 38994606
Introduction: Abundant evidence suggests that the overexpression of CDK2-cyclin A/E complex disrupts normal cell cycle regulation, leading to uncontrolled proliferation of cancer cells. Thus, CDK2 has become a promising therapeutic...
5.
Yuan H, Gui H, Chen S, Zhu L, Wang C, Jing Q, et al.
Int J Nanomedicine
. 2024 Apr;
19:3589-3605.
PMID: 38645464
Purpose: This study aimed to develop a novel and feasible modification strategy to improve the solubility and antitumor activity of resiquimod (R848) by utilizing the supramolecular effect of 2-hydroxypropyl-beta-cyclodextrin (2-HP-β-CD)....
6.
Wang M, Wan Q, Wang C, Jing Q, Nie Y, Zhang X, et al.
Mol Cell Biochem
. 2024 Mar;
480(1):445-458.
PMID: 38507020
Immunotherapy is regarded as a potent cancer treatment, with DC vaccines playing a crucial role. Although clinical trials have demonstrated the safety and efficacy of DC vaccines, loading antigens in...
7.
Jing Q, Wan Q, Nie Y, Luo J, Zhang X, Zhu L, et al.
Front Pharmacol
. 2024 Jan;
14:1286061.
PMID: 38161697
As psychoneuroimmunology flourishes, there is compelling evidence that depression suppresses the anti-tumor immune response, promotes the progression of cancer, and inhibits the effectiveness of cancer immunotherapy. Recent studies have reported...
8.
Gui H, Chen X, Li L, Zhu L, Jing Q, Nie Y, et al.
Int Immunopharmacol
. 2023 Jun;
121:110251.
PMID: 37348230
Lung cancer has the highest incidence rate and mortality worldwide. Moreover, multiple factors may cause heterogeneity in the efficacy of immunotherapy for lung cancer, and preclinical studies have gradually uncovered...
9.
Zhu L, Zhang X, Chen X, Yang D, Nie Y, Pan R, et al.
Biochem Biophys Res Commun
. 2023 Mar;
653:106-114.
PMID: 36868074
Immunotherapy is the new approach for cancer treatment that can be achieved through several strategies, one of which is dendritic cells (DCs) vaccine therapy. However, traditional DC vaccination lacks accurate...
10.
Zi Y, Gao J, Wang C, Guan Y, Li L, Ren X, et al.
Int J Biol Sci
. 2022 Mar;
18(4):1539-1554.
PMID: 35280671
Hyperactivation of Wnt/β-catenin signaling has been reported in hepatocellular carcinoma (HCC). However, the mechanisms underlying the hyperactivation of Wnt/β-catenin signaling are incompletely understood. In this study, Pantothenate kinase 1 (PANK1)...